Try our Advanced Search for more refined results
April 03, 2014
In Re: Aggrenox Antitrust Litigation
Case Number:
3:14-md-02516
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Ahern & Associates
- Baker Donelson
- Baker & Miller
- Ballard Spahr
- Barrett Johnston
- Bass Berry
- Berger Montague
- Blank Rome
- Brenner Saltzman
- Capozzi Adler
- Carmody Torrance
- Cohen Milstein
- Cohen Placitella
- Connolly Wells
- Cowdery Murphy
- Day Pitney
- DiCello Levitt
- Faruqi & Faruqi
- Garwin Gerstein
- Gibson Dunn
- Girard Sharp
- Glancy Prongay
- Goodwin Procter
- Grant & Eisenhofer
- Hagens Berman
- Hangley Aronchick
- Hausfeld LLP
- Hayber McKenna
- Heim Payne
- Heins Mills
- Hilliard & Shadowen
- Hurwitz Sagarin
- Jones Day
- Kenny Nachwalter
- Labaton Keller
- Latham & Watkins
- Lauletta Birnbaum
- Levin Sedran
- Lockridge Grindal
- Lowey Dannenberg
- McCune Wright
- Milberg Coleman
- Miller Shah LLP
- Motley Rice
- Norton Rose
- Nussbaum Law Group
- Odom & Des Roches
- Pomerantz LLP
- Pullman & Comley
- Quinn Connor Weaver
- Reinhardt Wendorf
- Shipman & Goodwin
- Simmons Hanly
- Smith Segura
- Spector Roseman
- Stevens & Lee
- Stoll Berne
- Taus Cebulash
- White & Case
- Wiley Rein
- Winstead PC
- Zayas Law Firm
- Zimmerman Reed
Companies
- Aetna Inc.
- Association for Accessible Medicines
- Bi-Lo
- BlueCross BlueShield of Tennessee Inc.
- Boehringer Ingelheim Vetmedica Inc.
- CVS Health Corp.
- Florida Blue
- Gyma Laboratories of America Inc.
- H‑E‑B LP
- Humana Inc.
- International Union of Painters & Allied Trades
- Rite Aid Corp.
- Rochester Drug Cooperative Inc.
- Safeway Inc.
- Teva Pharmaceutical Industries Ltd.
- The Cigna Group
- The Kroger Co.
- Winn-Dixie Stores, Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
October 29, 2019
Allergan's $750M Deal Among Pharma's Top Antitrust Payouts
A $750 million settlement this week by Allergan to avert an antitrust trial involving Alzheimer's drug Namenda is among the most eye-popping sums ever shelled out by a drugmaker for allegedly thwarting generic competition.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login